SCHEMBL29539482

SCHEMBL29539482

CN(c1cccc(-c2nn(-c3ccc(F)cc3)c(=O)c3ccccc23)c1)S(C)(=O)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 4/20 0.53
KDM4E B2RXH2 3/20 0.53
BRD4 O60885 1/20 0.53
ALOX5 P09917 1/20 0.53
ALDH1A1 P00352 3/20 0.50
LMNA P02545 2/20 0.50
PDE4A P27815 1/20 0.45
PDE4B Q07343 1/20 0.45
PDE4C Q08493 1/20 0.45
PDE4D Q08499 1/20 0.45
GAA P10253 4/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
HTT P42858 1/20 0.45
AURKA O14965 1/20 0.43
ENPP1 P22413 1/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22721783 1.00 NPSR1 (0.53) NPSR1KDM4EBRD4ALOX5ALDH1A1
SCHEMBL22721546 0.91 NPSR1 (0.57) NPSR1KDM4EBRD4ALOX5ALDH1A1
SCHEMBL29539373 0.91 NPSR1 (0.57) NPSR1KDM4EBRD4ALOX5ALDH1A1
SCHEMBL28696580 0.91 NPSR1 (0.52) NPSR1KDM4EBRD4ALOX5ALDH1A1
SCHEMBL30880166 0.91 NPSR1 (0.52) NPSR1KDM4EBRD4ALOX5ALDH1A1
SCHEMBL22721685 0.90 NPSR1 (0.51) NPSR1KDM4EBRD4ALOX5ALDH1A1
SCHEMBL29539556 0.90 NPSR1 (0.51) NPSR1KDM4EBRD4ALOX5ALDH1A1
SCHEMBL29539552 0.90 NPSR1 (0.51) NPSR1KDM4EBRD4ALOX5ALDH1A1
SCHEMBL22721568 0.89 NPSR1 (0.50) NPSR1KDM4EBRD4ALOX5ALDH1A1
SCHEMBL30880181 0.89 NPSR1 (0.50) NPSR1KDM4EBRD4ALOX5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220235011-A1 PHTHALAZINONE COMPOUNDS AND USE THEREOF ST PHARM CO., LTD. (KR) 2022-07-28 US claimed
EP-3978480-A1 PHTHALAZINONE COMPOUNDS AND USE THEREOF ST Pharm Co., Ltd. (KR) 2022-04-06 EP claimed
US-20220235011-A1 PHTHALAZINONE COMPOUNDS AND USE THEREOF ST PHARM CO., LTD. (KR) 2022-07-28 US disclosed
EP-3978480-A1 PHTHALAZINONE COMPOUNDS AND USE THEREOF ST Pharm Co., Ltd. (KR) 2022-04-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220235011-A1 PHTHALAZINONE COMPOUNDS AND USE THEREOF SIRT6, SIRT1, SIRT2 NPSR1 2979/4885KDM4E 635/4885BRD4 481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.